Tailored pre-transplant therapy boosts survival rate in rare immune deficiency
Tuesday, November 12, 2013 - 15:00
in Health & Medicine
Chronic Granulomatous Disease is a rare immune deficiency that is life-threatening. Tailored doses of the pre-transplant drug therapy boosts survival rates to over 90%.